iRhythm Technologies, Inc. (IRTC)
USD 99.74
(-5.83%)
USD 99.74
(-5.83%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 223.04 Million USD | 7.02% |
| 2022 | 208.41 Million USD | 13.6% |
| 2021 | 183.45 Million USD | 7.83% |
| 2020 | 170.12 Million USD | -0.4% |
| 2019 | 170.8 Million USD | 161.61% |
| 2018 | 65.28 Million USD | 21.87% |
| 2017 | 53.57 Million USD | 17.49% |
| 2016 | 45.59 Million USD | -67.32% |
| 2015 | 139.49 Million USD | 40.83% |
| 2014 | 99.05 Million USD | 1043.4% |
| 2013 | 8.66 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 819.99 Million USD | 0.06% |
| 2024 Q1 | 819.46 Million USD | 267.4% |
| 2024 Q3 | 837.92 Million USD | 2.19% |
| 2023 Q3 | 219.97 Million USD | 6.99% |
| 2023 Q2 | 205.6 Million USD | 2.87% |
| 2023 Q1 | 199.86 Million USD | -4.1% |
| 2023 Q4 | 223.04 Million USD | 1.4% |
| 2023 FY | 223.04 Million USD | 7.02% |
| 2022 Q1 | 183.87 Million USD | 0.23% |
| 2022 Q4 | 208.41 Million USD | 3.6% |
| 2022 FY | 208.41 Million USD | 13.6% |
| 2022 Q2 | 191.04 Million USD | 3.9% |
| 2022 Q3 | 201.16 Million USD | 5.3% |
| 2021 Q1 | 168.91 Million USD | -0.71% |
| 2021 Q4 | 183.45 Million USD | -0.52% |
| 2021 Q3 | 184.41 Million USD | 3.15% |
| 2021 FY | 183.45 Million USD | 7.83% |
| 2021 Q2 | 178.78 Million USD | 5.84% |
| 2020 Q2 | 158.27 Million USD | 0.2% |
| 2020 FY | 170.12 Million USD | -0.4% |
| 2020 Q4 | 170.12 Million USD | 4.59% |
| 2020 Q3 | 162.65 Million USD | 2.77% |
| 2020 Q1 | 157.96 Million USD | -7.52% |
| 2019 Q3 | 166.73 Million USD | 5.07% |
| 2019 Q2 | 158.68 Million USD | 135.23% |
| 2019 Q1 | 67.46 Million USD | 3.33% |
| 2019 FY | 170.8 Million USD | 161.61% |
| 2019 Q4 | 170.8 Million USD | 2.44% |
| 2018 Q3 | 55.03 Million USD | 4.92% |
| 2018 FY | 65.28 Million USD | 21.87% |
| 2018 Q2 | 52.45 Million USD | 5.54% |
| 2018 Q1 | 49.69 Million USD | -7.23% |
| 2018 Q4 | 65.28 Million USD | 18.64% |
| 2017 Q2 | 46.95 Million USD | 7.96% |
| 2017 Q4 | 53.57 Million USD | 10.99% |
| 2017 Q3 | 48.26 Million USD | 2.8% |
| 2017 Q1 | 43.48 Million USD | -4.62% |
| 2017 FY | 53.57 Million USD | 17.49% |
| 2016 Q4 | 45.59 Million USD | -67.96% |
| 2016 Q2 | 139.98 Million USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2016 FY | 45.59 Million USD | -67.32% |
| 2016 Q3 | 142.3 Million USD | 1.66% |
| 2015 Q4 | 139.49 Million USD | 983.72% |
| 2015 Q3 | 12.87 Million USD | 0.0% |
| 2015 Q1 | - USD | -100.0% |
| 2015 FY | 139.49 Million USD | 40.83% |
| 2014 FY | 99.05 Million USD | 1043.4% |
| 2014 Q4 | 11.24 Million USD | 0.0% |
| 2013 FY | 8.66 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -335.18% |
| BrainsWay Ltd. | 15.31 Million USD | -1356.491% |
| Cerus Corporation | 144.3 Million USD | -54.567% |
| Envoy Medical, Inc. | 9.4 Million USD | -2272.336% |
| electroCore, Inc. | 8.94 Million USD | -2393.538% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -4075.346% |
| IceCure Medical Ltd | 4.24 Million USD | -5151.872% |
| Inogen, Inc. | 121.38 Million USD | -83.756% |
| OrthoPediatrics Corp. | 72.56 Million USD | -207.392% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -654.021% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -6909.774% |
| MaxCyte, Inc. | 36.1 Million USD | -517.739% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -11970.231% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -52346.97% |
| Orthofix Medical Inc. | 326.58 Million USD | 31.703% |
| PAVmed Inc | 57.13 Million USD | -290.372% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -775.965% |
| RxSight, Inc. | 22.18 Million USD | -905.26% |
| Sight Sciences, Inc. | 46.43 Million USD | -380.332% |
| SI-BONE, Inc. | 61.05 Million USD | -265.351% |
| TELA Bio, Inc. | 59.16 Million USD | -276.979% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -95.708% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -2061.518% |
| Acutus Medical, Inc. | 54.83 Million USD | -306.731% |
| Talis Biomedical Corporation | 29.22 Million USD | -663.232% |
| Spectral AI, Inc. | 12.4 Million USD | -1698.621% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -864.152% |
| CVRx, Inc. | 39.28 Million USD | -467.81% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -1765.241% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -9081.534% |
| Bioventus Inc. | 589.79 Million USD | 62.182% |
| Venus Concept Inc. | 107.1 Million USD | -108.255% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -331.735% |
| LivaNova PLC | 1.15 Billion USD | 80.637% |
| 908 Devices Inc. | 37.49 Million USD | -494.951% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 68.294% |
| Nemaura Medical Inc. | 26.37 Million USD | -745.598% |
| NeuroPace, Inc. | 86.99 Million USD | -156.385% |
| LENSAR, Inc. | 22.4 Million USD | -895.346% |
| Apyx Medical Corporation | 52.31 Million USD | -326.329% |
| Cutera, Inc. | 518.12 Million USD | 56.951% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -660.526% |
| BioSig Technologies, Inc. | 4.68 Million USD | -4660.875% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -282.146% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -938.007% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 89.834% |
| Axonics, Inc. | 82.35 Million USD | -170.823% |
| Outset Medical, Inc. | 190.91 Million USD | -16.831% |
| IRIDEX Corporation | 24.91 Million USD | -795.268% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -79.927% |
| IRadimed Corporation | 20.73 Million USD | -975.654% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -13224.194% |
| INVO Bioscience, Inc. | 19.99 Million USD | -1015.516% |
| Telesis Bio, Inc. | 40.87 Million USD | -445.707% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -446.815% |
| Varex Imaging Corporation | 668.6 Million USD | 66.64% |
| Quipt Home Medical Corp. | 136.29 Million USD | -63.653% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -6144.317% |
| Pulmonx Corporation | 60.63 Million USD | -267.846% |
| Dynatronics Corporation | 11.78 Million USD | -1793.42% |
| Modular Medical, Inc. | 2.27 Million USD | -9717.21% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -5388.361% |
| Semler Scientific, Inc. | 6.27 Million USD | -3457.368% |
| InMode Ltd. | 75.91 Million USD | -193.815% |
| Bruker Corporation | 2.83 Billion USD | 92.137% |
| Cytosorbents Corporation | 29.98 Million USD | -643.85% |
| DexCom, Inc. | 4.19 Billion USD | 94.684% |
| Align Technology, Inc. | 2.45 Billion USD | 90.909% |
| Viveve Medical, Inc. | 10.84 Million USD | -1956.301% |
| ZimVie Inc. | 795.85 Million USD | 71.974% |
| Movano Inc. | 5.97 Million USD | -3634.879% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -113.228% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -52346.97% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -1765.241% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 65.096% |
| Profound Medical Corp. | 12.66 Million USD | -1661.009% |
| Insulet Corporation | 1.85 Billion USD | 87.979% |
| enVVeno Medical Corporation | 2.43 Million USD | -9060.041% |
| Surmodics, Inc. | 65.82 Million USD | -238.859% |
| iCAD, Inc. | 8 Million USD | -2687.739% |
| Nuwellis, Inc. | 6.78 Million USD | -3189.779% |
| Biotricity, Inc. | 35.91 Million USD | -520.965% |
| Aethlon Medical, Inc. | 2.47 Million USD | -8895.1% |
| InspireMD, Inc. | 8.14 Million USD | -2639.462% |
| PAVmed Inc. | 57.13 Million USD | -290.372% |
| BIOLASE, Inc. | 35.34 Million USD | -531.003% |
| Beyond Air, Inc. | 29.77 Million USD | -649.108% |
| FONAR Corporation | 57.45 Million USD | -288.194% |
| AxoGen, Inc. | 101.16 Million USD | -120.485% |
| Vivani Medical, Inc. | 25.03 Million USD | -790.905% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -154.051% |
| Inari Medical, Inc. | 209.32 Million USD | -6.555% |
| UFP Technologies, Inc. | 118.04 Million USD | -88.951% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -1657.591% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -10104.309% |
| Tenon Medical, Inc. | 5.56 Million USD | -3906.592% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -12437.774% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -1164.861% |
| AdaptHealth Corp. | 3.15 Billion USD | 92.926% |
| Sintx Technologies, Inc. | 6.59 Million USD | -3283.088% |
| NanoVibronix, Inc. | 2.68 Million USD | -8204.058% |
| Quanterix Corporation | 78.08 Million USD | -185.65% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -6144.317% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -4465.957% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 78.65% |
| TransMedics Group, Inc. | 568.84 Million USD | 60.789% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -1237.052% |
| NeuroMetrix, Inc. | 1.33 Million USD | -16631.152% |
| Hyperfine, Inc. | 9.8 Million USD | -2175.99% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 10.869% |
| Biomerica, Inc. | 2.66 Million USD | -8275.779% |
| Bone Biologics Corporation | 831.4 Thousand USD | -26727.816% |
| AVITA Medical, Inc. | 19.86 Million USD | -1022.791% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -11201.055% |
| Silk Road Medical, Inc | 114.15 Million USD | -95.384% |